# Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors

> **NCT07146672** · PHASE1,PHASE2 · RECRUITING · sponsor: **Shanghai Cell Therapy Group Co.,Ltd** · enrollment: 12 (estimated)

## Conditions studied

- Solid Tumor Cancer

## Interventions

- **BIOLOGICAL:** Super DC Vaccine

## Key facts

- **NCT ID:** NCT07146672
- **Lead sponsor:** Shanghai Cell Therapy Group Co.,Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-31
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2025-08-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07146672

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07146672, "Exploratory Study of Super DC Cell Injection in Preventing Recurrence After Radical Surgery for Tumors". Retrieved via AI Analytics 2026-07-05 from https://api.ai-analytics.org/clinical/NCT07146672. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*